NCT03158298

Brief Summary

The study intends to examine the association between schistosomiasis seropositivity and adverse pregnancy outcomes. It aims at the verification of the hypothesis that in pregnant women originating from endemic areas for schistosomiasis, positive serology is associated with reduced Infant birth weight.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2017

Completed
14 days until next milestone

Study Start

First participant enrolled

June 1, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2019

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

April 14, 2022

Completed
Last Updated

April 14, 2022

Status Verified

April 1, 2022

Enrollment Period

1.4 years

First QC Date

May 16, 2017

Results QC Date

July 6, 2020

Last Update Submit

April 13, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Schistosoma Serology

    Presence of Schistosoma antibodies in maternal serum

    6 month after delivery

Secondary Outcomes (4)

  • Birth Weight

    1 hour upon delivery

  • Preterm Birth

    24 hours before delivery

  • Intrauterine Growth Restriction

    48 hours after delivery

  • Stillbirth

    At delivery

Interventions

Maternal blood sample of 10 ml collected by venepuncture upon delivery

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsStudy objectives pertain to pregnant women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women aged above 18, who migrated to Europe from geographic regions with endemic schistosomiasis

You may qualify if:

  • Pregnancy
  • Immigration from a country/geographic area with declared endemic schistosomiasis according to World Health Organization criteria
  • Signed informed consent

You may not qualify if:

  • Placenta pathology of any cause
  • Any medical condition affecting fetal growth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Jena

Jena, Thuringia, 07747, Germany

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum Placenta (optional)

MeSH Terms

Conditions

Schistosomiasis

Interventions

Specimen Handling

Condition Hierarchy (Ancestors)

Trematode InfectionsHelminthiasisParasitic DiseasesInfectionsVector Borne Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Limitations and Caveats

Early termination leading to small numbers of subjects analyzed

Results Point of Contact

Title
Dr. Benjamin Schleenvoigt
Organization
Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany

Study Officials

  • Benjamin Schleenvoigt, M.D.

    Center for Infectious Diseases and Infection Control, Jena University Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2017

First Posted

May 18, 2017

Study Start

June 1, 2017

Primary Completion

October 31, 2018

Study Completion

October 11, 2019

Last Updated

April 14, 2022

Results First Posted

April 14, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations